feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Synact Pharma: Interview with CEO Jeppe Øvlesen and CSO Thomas Jonassen (video call)
Research Interview
2020-05-12
15:20
Synact Pharma comments on its early Phase IIa data in Rheumatoid Arthritis.
LS
Ludvig Svensson
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans